Madrigal Pharmaceuticals (MDGL) Research & Development (2019 - 2025)
Historic Research & Development for Madrigal Pharmaceuticals (MDGL) over the last 13 years, with Q3 2025 value amounting to $174.0 million.
- Madrigal Pharmaceuticals' Research & Development rose 15312.62% to $174.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $297.9 million, marking a year-over-year increase of 574.88%. This contributed to the annual value of $236.7 million for FY2024, which is 1308.32% down from last year.
- Latest data reveals that Madrigal Pharmaceuticals reported Research & Development of $174.0 million as of Q3 2025, which was up 15312.62% from $54.1 million recorded in Q2 2025.
- Madrigal Pharmaceuticals' 5-year Research & Development high stood at $174.0 million for Q3 2025, and its period low was $25.6 million during Q4 2024.
- Its 5-year average for Research & Development is $64.8 million, with a median of $62.2 million in 2023.
- In the last 5 years, Madrigal Pharmaceuticals' Research & Development tumbled by 6369.2% in 2024 and then soared by 15312.62% in 2025.
- Quarter analysis of 5 years shows Madrigal Pharmaceuticals' Research & Development stood at $52.9 million in 2021, then soared by 33.76% to $70.7 million in 2022, then dropped by 0.14% to $70.6 million in 2023, then tumbled by 63.69% to $25.6 million in 2024, then soared by 578.43% to $174.0 million in 2025.
- Its Research & Development was $174.0 million in Q3 2025, compared to $54.1 million in Q2 2025 and $44.2 million in Q1 2025.